Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedSite updated from version 3.4.2 to 3.4.3; no changes to study content or user-facing functionality are evident.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice about government funding and the previous Revision: v3.4.1. These are administrative changes and do not affect the study information on the page.SummaryDifference0.3%

- Check42 days agoChange DetectedThe page now includes a government funding lapse notice indicating the NIH Clinical Center is open and operations may be affected, and the site version has been updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check85 days agoChange DetectedLocations section added listing study sites across multiple states and Ontario. Revision updated to v3.3.3.SummaryDifference2%

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.